ACS Low Risk Discharge Eligibility Tool

Clinical calculation support · Verify results before clinical use

Discharge assessment

Enter the current clinical status to structure an early-discharge review.

Enter elapsed length of stay in days.
For STEMI treated with primary PCI only. Enter a calculated score from 0 to 16. A missing score does not confirm low risk.
Interpret troponin together with symptoms, ECG, timing, and the clinical context; a falling value alone does not establish discharge safety.

Clinical context

This tool structures a bedside review of patients with acute coronary syndrome when discharge is being considered. It combines clinical stability items with length of stay and, for STEMI treated with primary PCI, the Zwolle Risk Score.

The 2025 ACC/AHA acute coronary syndromes guideline notes that an early discharge strategy of less than three days may be appropriate for selected low-risk STEMI patients after PCI. A Zwolle score of 3 or less can help identify patients for possible discharge at 48 to 72 hours, provided the patient is clinically stable and has no unresolved concerns.

For NSTE-ACS, evidence for very early or same-day discharge is less extensive. Clinical stability, absence of ongoing ischemia, acute kidney injury, significant LV dysfunction or heart failure, and procedural complications should be considered alongside medication access and follow-up arrangements.

Practical safeguards

  • Confirm the overall clinical course, ECG findings, procedural result, and treatment plan.
  • Assess left ventricular ejection fraction and address any heart failure or other complication.
  • Ensure secondary prevention, medication access, patient education, cardiac rehabilitation referral when appropriate, and timely follow-up.
  • Do not use this pathway to override clinician concern or local discharge protocols.
Clinical disclaimer: This tool is intended for clinician decision support and does not replace individualized assessment, current guidelines, institutional protocols, or shared decision-making. It is not a validated stand-alone discharge rule, particularly for NSTE-ACS or medically managed patients. Confirm all relevant clinical details before making a discharge decision.